MAGEA9 is frequently overexpressed in bladder cancer, cutaneous T-cell lymphomas, oesophageal adenocarcinomas, as well as in renal cell carcinoma [51,52,53,54]. The gene discussed is MAGEA9; the disease is esophageal adenocarcinoma.